Updates

Date: 8th July, 2026 BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400 051 Ref.: BSE Scrip Code No. “533138” Ref.: “ASTEC” Debt Segment NSE: NCD-ASTEC-ISIN: INE563J08023 Dear Sir / Madam, Subject: (1) Annual Report for the Financial Year 2025-26 (2)Notice of 32nd (Thirty-Second) Annual General Meeting (3)Notice of Circulation of Letter containing Web-link of Annual Report (4) Notice of Book Closure Pursuant to Regulations 30, 34, 36(1), 50(2) and 53 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited (“Company”) for the Financial Year 2025-26, containing, inter alia, the Notice of the 32nd (Thirty-Second) Annual General Meeting (“AGM”) of the Company scheduled to be held on Friday, 31st July, 2026 at 4.00 p.m. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). The Annual Report of the Company for the Financial Year 2025-26 [comprising of, inter alia, Audited Standalone and Consolidated Financial Statements, Reports of the Board of Directors and the Statutory Auditors for the said Financial Year, Notice of the AGM], is also available on the website of the Company, viz., www.godrejastec.com at the weblink https://www.godrejastec.com/ investors/annual-reports. Further, this is to inform that the Company has issued letters to all the Shareholders whose e- mail addresses are not registered with the Company or Depository Participants or the Company’s Registrar and Share Transfer Agent, viz., Bigshare Services Private Limited, containing the weblink from where the Shareholders can access the Annual Report the Company’s website. The letter in this regard is enclosed herewith. We further wish to inform that pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the Listing Regulations, the Register of Members and the Share Transfer Books of the Company will remain closed for the purpose of the 32nd (Thirty-Second) AGM from Sunday, 26th July, 2026 to Thursday, 30th July, 2026 (both days inclusive). The remote e-voting period commences on Sunday, 26th July, 2026 at 9.00 a.m. (IST) and ends on Thursday, 30th July, 2026 at 5.00 p.m. (IST). During this period, the Shareholders of the Company, holding shares either in physical form or in dematerialized form, as on the Cut-off date, i.e., Friday, 24th July, 2026, may cast their votes by remote e-voting. Please take note of the above. Thanking you, Yours faithfully, For Astec LifeSciences Limited Tejashree Pradhan Company Secretary & Compliance Officer (FCS 7167) Encl.: (1) Annual Report for the Financial Year 2025-26 (2) Copy of Specimen Letter containing the Web-link of Annual Report Trust Transparency Agility ANNUAL 2026 REPORT Business Overview Statutory Reports Financial Statements Inside the Report … Business Overview Statutory Report s Our Values 02 AGM Notice 32 Board of Directors 04 Directors' Report 45 From Director's Office 06 Corporate Governance Report 74 About Us 10 Business Responsibility 108 and Sustainability Report Geographical Footprints 11 Corporate Information 12 Astec LifeSciences - At a Glance 14 Management Discussion 15 and Analysis Report Financial Statement s Standalone Financials 145 and Auditor's Report Consolidated Financials 211 and Auditor's Report DDiisscclalaimimerer: TThhee ssttaatetemmenetn int tihne t“hMea n“aMgaemnaegnte Dmisecnuts sDioins caundss Aionnal yasnisd R eApnoartly” sdiess cRreibpeo yrotu”r Cdoemscprainbye’s y oobujerc tCivoems, ppraonjeyc’tsi oonbs,j eescttimivaetse,s panrodjections, expectations which may be “forward-looking statements” within the meaning of the applicable laws and regulations. The actual results estimates and expectations which may be “forward-looking statements” within the meaning of the applicable laws and could differ materially from those expressed or implied, depending upon the economic and climatic conditions, government policies, rteagxautliaotni oannds .o Tthheer laacwtsu aanl dr eosthueltrs in ccoiduelndt adli ffafcetro mrs.aterially from those expressed or implied, depending upon the economic and climatic conditions, government policies, taxation and other laws and other incidental factors. GODREJ Rooted in values. Adventurous about the future. For now, next and forever. OUR VALUES Inspire Trust Create Delight Be Bold We lead with integrity, listen with We design to delight, move fast, and build We dream big, deliver now, and grow humility, and earn trust that endures. what the world loves. stronger through every challenge. Crafting tomorrow since 1897 BOARD OF DIRECTORS Mr. Nadir Godrej Mr. Vishal Sharma Mr. Sunil Kataria Mr. R. R. Govindan Mr. Nandkumar Dhekne Ms. Anjali Gupte Chairman - Non-Executive Chairperson - Non-Executive Non-Executive Director Independent Director Independent Director Independent Director (Upto close of business hours (W.e.f. close of business hours (W.e.f. 1st September, 2025) on 13th April, 2026) on 13th April, 2026) Mr. Burjis N. Godrej Mr. Ashok V. Hiremath Mr. Balram Singh Yadav Dr. Ganapati Yadav Mr. Mathew Eipe Mr. Arijit Mukherjee Non-Executive Director Non-Executive Director Non-Executive Director Independent Director Independent Director Executive Director (W.e.f. close of business hours on 13th April, 2026, (Upto close of business hours on 31st August, 2025) (W.e.f. 13th April, 2026) (W.e.f. 13th April, 2026) formerly Managing Director) Mr. R. R. Govindan Mr. Nandkumar Dhekne Ms. Anjali Gupte Independent Director Independent Director Independent Director Dr. Ganapati Yadav Mr. Mathew Eipe Mr. Arijit Mukherjee Independent Director Independent Director Executive Director (W.e.f. 13th April, 2026) (W.e.f. 13th April, 2026) FROM DIRECTOR'S OFFICE Burjis N. Godrej Dear Shareholders, It is my privilege to present the Annual Report of your Company for the Financial Year 2025–26. The year under review unfolded amid a complex and evolving global environment. Persistent geopolitical tensions, shifting trade dynamics, and climate variability continued to create uncertainty across markets. The agrochemical industry, in particular, witnessed a gradual transition from a phase of inventory correction toward volume normalization, even as pricing remained under pressure due to competitive intensity and supply-side realignments. In this backdrop, India continued to demonstrate resilience, supported by strong domestic demand, stable macroeconomic fundamentals, and an increasingly favorable policy framework. The agricultural sector remains central to this growth narrative, driving rural demand while undergoing a structural transition toward productivity-led and technology-enabled practices. Against this dynamic landscape, your Company remained focused on strengthening its core businesses, improving execution discipline. Strategizing for Sustainable and Resilient Growth Financial Year 2025–26 was a year that required calibrated responses and disciplined execution. The operating environment for B2B agrochemicals—especially in enterprise products and Contract Development and Manufacturing Organization (CDMO) —remained challenging in the first half, impacted by destocking, subdued demand, and price corrections. Your Company delivered a strong turnaround, achieving EBITDA break-even for the year. Improved volumes, better realizations, and higher capacity utilization across Enterprise and CDMO portfolios positioned your company for sustained recovery. However, as the year progressed, early signs of stabilization emerged, with recovery being driven largely by volume growth rather than pricing. In this context, our focus remained clearly anchored on: • Improving volume traction across enterprise and CDMO businesses • Enhancing product mix and realisations [Showing first 8,000 characters — download PDF for full document]